Decreased Muscle Strength in Children With Repaired Tetralogy of Fallot: Relation With Exercise Capacity.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
06 06 2023
Historique:
medline: 7 6 2023
pubmed: 23 5 2023
entrez: 23 5 2023
Statut: ppublish

Résumé

Background The aim of this study is to describe muscle strength in pediatric patients with repaired tetralogy of Fallot compared with healthy peers and to analyze the correlation between muscle strength and peak oxygen uptake, exercise capacity (mL/min). Methods and Results A prospective, cross-sectional study was carried out in the University Medical Center Groningen between March 2016 and December 2019, which included 8 -to-19-year-old patients with repaired tetralogy of Fallot. Exclusion criteria comprised the following: Down syndrome, unstable pulmonary disease and severe scoliosis affecting pulmonary function, neuromuscular disease, and mental or physical limitations that prohibit the execution of the functional tests. Muscle strength was compared with 2 healthy pediatric cohorts from the Northern Netherlands. Handgrip strength, maximal voluntary isometric contraction, and dynamic muscle strength in correlation with peak oxygen uptake, exercise capacity (mL/min) were the main outcomes of the study. The 67 patients with repaired tetralogy of Fallot (42% female; aged 12.9 [interquartile range, 10.0-16.3] years old) were compared with healthy children. The patients showed reduced grip strength (

Identifiants

pubmed: 37218581
doi: 10.1161/JAHA.122.027937
pmc: PMC10381998
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e027937

Références

Int J Cardiol. 2013 Nov 30;169(6):439-44
pubmed: 24182670
Pediatr Nephrol. 2020 May;35(5):891-899
pubmed: 31932960
Pediatr Cardiol. 2019 Jan;40(1):71-78
pubmed: 30121867
Clin Interv Aging. 2019 Oct 01;14:1681-1691
pubmed: 31631989
Int J Cardiol. 2014 Jan 1;170(3):358-63
pubmed: 24295897
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):93A-98A
pubmed: 8376701
Circ Cardiovasc Imaging. 2021 Aug;14(8):e011823
pubmed: 34384226
Pediatr Cardiol. 2021 Apr;42(4):857-865
pubmed: 33484289
Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S53-S58
pubmed: 28362512
J Phys Ther Sci. 2020 Feb;32(2):120-124
pubmed: 32158074
Eur Heart J. 2012 Jun;33(11):1386-96
pubmed: 22199119
ERJ Open Res. 2019 Apr 01;5(2):
pubmed: 30949491
PLoS One. 2015 Nov 23;10(11):e0143476
pubmed: 26599429
Eur Heart J Cardiovasc Imaging. 2020 Jan 1;21(1):102-113
pubmed: 31280290
Heart. 2011 Jul;97(14):1164-8
pubmed: 21258001
PLoS One. 2018 Mar 29;13(3):e0194531
pubmed: 29596450
Int J Cardiovasc Imaging. 2020 Oct;36(10):1997-2005
pubmed: 32472300
Cardiol Young. 2019 Feb;29(2):133-139
pubmed: 30474577
Front Pediatr. 2018 Sep 06;6:247
pubmed: 30238000
Am Heart J. 2013 Apr;165(4):551-7
pubmed: 23537972
Neuromuscul Disord. 2001 Jul;11(5):441-6
pubmed: 11404114
Int J Cardiol. 2016 Jul 15;215:487-93
pubmed: 27131770
Echocardiography. 2011 Oct;28(9):1019-24
pubmed: 21929568
Circulation. 1992 Apr;85(4):1364-73
pubmed: 1555280
Cardiovasc Eng Technol. 2022 Feb;13(1):41-54
pubmed: 34169460
Int J Environ Res Public Health. 2021 May 30;18(11):
pubmed: 34070726
Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77
pubmed: 12524257
Eur J Cardiothorac Surg. 2014 Feb;45(2):e6-12
pubmed: 24186927
Circulation. 2021 Feb 2;143(5):e35-e71
pubmed: 33332149
Cell Mol Life Sci. 2016 Nov;73(22):4175-4202
pubmed: 27271751
J Orthop Sports Phys Ther. 1992;16(5):215-9
pubmed: 18796752
Heart. 2022 Feb;108(3):186-193
pubmed: 33990411
Front Cardiovasc Med. 2022 May 04;9:874700
pubmed: 35600470
Am J Cardiol. 2011 Jul 1;108(1):99-105
pubmed: 21529748
Compr Physiol. 2015 Sep 20;5(4):1947-69
pubmed: 26426472
J Cardiol. 2018 Jan;71(1):88-92
pubmed: 28687271
Eur Heart J. 2021 Feb 11;42(6):563-645
pubmed: 32860028
Eur J Pediatr. 2010 Mar;169(3):281-7
pubmed: 19526369
Cardiovasc Diagn Ther. 2019 Oct;9(Suppl 2):S187-S197
pubmed: 31737527
Ann Med. 2020 May - Jun;52(3-4):109-119
pubmed: 32223654

Auteurs

Graziëlla Eshuis (G)

Department of Pediatric Cardiology University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Center for Congenital Heart Disease Groningen The Netherlands.

Hiske van Duinen (H)

Department of Biomedical Sciences of Cells & Systems, Section of Anatomy & Medical Physiology University of Groningen, University Medical Center Groningen Groningen The Netherlands.

Otto T H M Lelieveld (OTHM)

Department of Rehabilitation University of Groningen, University Medical Center Groningen Groningen The Netherlands.

Anneke K Hegeman (AK)

Department of Rehabilitation University of Groningen, University Medical Center Groningen Groningen The Netherlands.

Hessel Nijenhuis (H)

Department of Pediatric Cardiology University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Center for Congenital Heart Disease Groningen The Netherlands.

Tineke P Willems (TP)

Department of Radiology University of Groningen, University Medical Center Groningen Groningen The Netherlands.

Ann M Hepping (AM)

Roessingh Center for Rehabilitation Enschede The Netherlands.
Department of Orthopedics University of Groningen, University Medical Center Groningen Groningen The Netherlands.

Natasha Maurits (N)

Department of Neurology University of Groningen, University Medical Center Groningen Groningen The Netherlands.

Gideon J du Marchie Sarvaas (GJ)

Department of Pediatric Cardiology University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Center for Congenital Heart Disease Groningen The Netherlands.

Rolf M F Berger (RMF)

Department of Pediatric Cardiology University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Center for Congenital Heart Disease Groningen The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH